Healthtech startup Curelink has raised $3.5 million in seed funding from Elevation Capital and Venture Highway.
In this round, many investors also participated including Digital Sparrow Capital and angels such as Vijay Shekhar Sharma (Paytm), Prashant Tandon (Tata 1mg), Ankush Sachdeva and Farid Ahsan (Sharechat), Gaurav Agarwal, Rajat K Dhawan (McKinsey), Rohit MA (Cloudnine), Ritesh Malik (Innov8) and Harsh Mahajan (Mahajan Imaging) among others.
The startup plans to use the funds for geographical expansion and diversification of services across different medical specialisations such as dermatology, pediatrics, and psychiatry.
“Today, 200 million people have diseases such as hypertension, PCOS, and diabetes. Many of these people, especially older ones, do not spend much time on the internet and are unlikely to download a separate app to manage their health issues. They are however comfortable using WhatsApp to communicate with familiar medical professionals,” said Curelink’s founder Aman Singla.
Gurugram-based healthtech startup was founded in 2021 by IIT-Roorkee graduates Aman Singla and Divyansh Jain, CureLink serves as a platform to help doctors and medical care providers to reach out to patients through WhatsApp.
“Curelink converts vague advice, such as ‘change your diet’ to actionable advice thereby enabling time-strapped doctors to give personalised, accurate and in-depth care to such patients”, Aman added.
Divyansh Jain, founder of Curelink, said, “The tragedy of the Indian chronic care ecosystem is the lack of actionable advice that patients can refer to for managing diseases. We enable doctors to provide support to patients in an effortless manner yet exhaustive”.
“Doctors are the focal point of healthcare delivery in India, and Curelink’s model of being a trusted aide to doctors resonated immediately with us. The team is hyper-focused on their stakeholders, which is amply evident in design choices they have made, being WhatsApp-first for patients, enabling private and contextual consultations for doctors, and being squarely focused on outcomes,” said Vasudha Wadhera, VP, Elevation Capital.
According to CureLink, it intends to restart chronic care management for people in Tier 2 cities and beyond. Currently, CureLink is active in Gurugram and Bhopal and is planning to expand to the Delhi NCR region and roll out to cities like Lucknow and Jaipur by the end of 2022.
